3 Department of Hematology, School of Medical Sciences, Universiti Sains Malaysia, Malaysia Introduction AL amyloidosis may develop in patients with multiple myeloma (MM) or may progress from ...

Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are white blood cells that help you fight infection by making antibodies. Multiple myeloma starts in the plasma ...

Advanced treatment at Loyola University Medical Center is offering remission from a rare blood cancer. Thanks to Loyola’s ...

Multiple myeloma (also referred to as myeloma) is a type of rare, incurable cancer of the blood—also known as hematologic cancer. It affects cells called plasma cells, which are types of white blood ...

Dysphagia is an uncommon presentation of systemic immunoglobulin light-chain (AL) amyloidosis with multiple myeloma (MM). Gastrointestinal (GI) involvement usually manifests with altered motility, ...

It may also occur in association with multiple myeloma (Smith, 2003). Secondary amyloidosis occurs in association with chronic inflammatory or infectious diseases. Most patients who are diagnosed ...

Janssen has submitted a new combination regimen for its blockbuster multiple myeloma drug Darzalex for ... and potentially fatal disease light chain amyloidosis. The original IV version of ...

Pomalyst (pomalidomide) is a prescription drug that’s used to treat multiple myeloma in adults. Pomalyst is also available as a generic drug. Pomalyst comes as an oral capsule. The active ...

For some types of cancer, risk factors are known for the majority of cases. For example, smoking causes most lung cancers. This provides an opportunity for prevention. With multiple myeloma, few cases ...

Despite being the second most common haematologic cancer globally, treatment options for multiple myeloma remain limited, with a significant need for new therapies. 1 Multiple myeloma originates i ...